REAL-WORLD CLINICAL OUTCOMES AND PATHOLOGIC FEATURES OF BRAF V600E-MUTATED LUNG ADENOCARCINOMA PATIENTS IN TAIWAN

被引：0
|
作者：
Gow, Chien-Hung [1 ]
Hsieh, Min-Shu [2 ]
Shih, Jin-Yuan [2 ]
机构：
[1] Far Eastern Mem Hosp, New Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP563
引用
收藏
页码：295 / 295
页数：1
相关论文
共 50 条
  • [21] Impact of BRAF/MEK inhibitor on BRAF V600E-mutated pilocytic astrocytoma
    Hamada, Ryo
    Akane, Yusuke
    Akiyama, Yukinori
    Takada, Kohichi
    Yamamoto, Masaki
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [22] Extended 73-month survival in an elderly patient with BRAF V600E-mutated lung adenocarcinoma: A case report
    Namba, Kensuke
    Isobe, Kazutoshi
    Wakabayashi, Hiroki
    Ohashi, Ryogo
    Sakurai, Hiromasa
    Sakai, Daiki
    Irie, Yusuke
    Takashima, Kenta
    Murakami, Yu
    Kaneko, Kaichi
    Hiruta, Nobuyuki
    Matsuzawa, Yasuo
    RESPIROLOGY CASE REPORTS, 2024, 12 (10):
  • [23] Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
    Gallois, C.
    Bergen, E. S.
    Auclin, E.
    Pernot, S.
    Higue, J.
    Trouilloud, I.
    Touchefeu, Y.
    Turpin, A.
    Mazard, T.
    Sartore-Bianchi, A.
    Prenen, H.
    Alberti, A.
    Pilla, L.
    Cuissy, S.
    Wookey, V.
    Perret, A.
    Melchior, C.
    Artru, P.
    Dubreuil, O.
    Drouillard, A.
    Doat, S.
    Lavole, J.
    Basile, D.
    Perkins, G.
    Jary, M.
    Stintzing, S.
    Jos, J.
    Tougeron, D.
    Taieb, J.
    ESMO OPEN, 2024, 9 (09)
  • [24] Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
    Al Hashmi, Muna
    Konduru, Seetharama S.
    Silcock, Lee
    Chouchane, Lotfi
    Mattei, Valentina
    James, Nicola
    Mathew, Rebecca
    Bedognetti, Davide
    De Giorgi, Valeria
    Murtas, Daniela
    Liu, Wei
    Chouchane, Aouatef
    Temanni, Ramzi
    Seliger, Barbara
    Wang, Ena
    Marincola, Francesco M.
    Tomei, Sara
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [25] Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
    Muna Al Hashmi
    Konduru S. Sastry
    Lee Silcock
    Lotfi Chouchane
    Valentina Mattei
    Nicola James
    Rebecca Mathew
    Davide Bedognetti
    Valeria De Giorgi
    Daniela Murtas
    Wei Liu
    Aouatef Chouchane
    Ramzi Temanni
    Barbara Seliger
    Ena Wang
    Francesco M. Marincola
    Sara Tomei
    Journal of Translational Medicine, 18
  • [26] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Roviello, Giandomenico
    D'Angelo, Alberto
    Petrioli, Roberto
    Roviello, Franco
    Cianchi, Fabio
    Nobili, Stefania
    Mini, Enrico
    Lavacchi, Daniele
    TRANSLATIONAL ONCOLOGY, 2020, 13 (09):
  • [27] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Sharma, Vinod
    Vanidassane, Ilavarasi
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 876 - 876
  • [28] Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF V600E-Mutated Thyroid Cancer
    Jeon, Youngkyung
    Park, Sehhoon
    Lee, Se-Hoon
    Kim, Tae Hyuk
    Kim, Sun Wook
    Ahn, Myung-Ju
    Jung, Hyun Ae
    Chung, Jae Hoon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (04): : 1270 - 1276
  • [29] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Kopetz, S.
    Grothey, A.
    Yaeger, R.
    Van Cutsem, E.
    Desai, J.
    Yoshino, T.
    Wasan, H.
    Ciardiello, F.
    Loupakis, F.
    Hong, Y. S.
    Steeghs, N.
    Guren, T. K.
    Arkenau, H. -T.
    Garcia-Alfonso, P.
    Pfeiffer, P.
    Orlov, S.
    Lonardi, S.
    Elez, E.
    Kim, T. -W.
    Schellens, J. H. M.
    Guo, C.
    Krishnan, A.
    Dekervel, J.
    Morris, V.
    Calvo Ferrandiz, A.
    Tarpgaard, L. S.
    Braun, M.
    Gollerkeri, A.
    Keir, C.
    Maharry, K.
    Pickard, M.
    Christy-Bittel, J.
    Anderson, L.
    Sandor, V.
    Tabernero, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1632 - 1643
  • [30] BRAF V600E-mutated combined large cell neuroendocrine carcinoma and adenocarcinoma responding to targeted therapy
    Sakamoto, Tomohiro
    Arai, Katsunori
    Makishima, Karen
    Yamasaki, Akira
    BMJ CASE REPORTS, 2021, 14 (12)
12345